Please wait while the formulary information is being retrieved.
Drug overview for CEFEPIME HCL (cefepime hcl):
Generic name: CEFEPIME HCL (SEF-e-peem)
Drug class: Beta-Lactams
Therapeutic class: Anti-Infective Agents
Cefepime is a semisynthetic, fourth generation cephalosporin antibiotic.
Cefepime is used for the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, and moderate to severe pneumonia caused by susceptible organisms. For the treatment of complicated intra-abdominal infections, cefepime is used in conjunction with IV metronidazole. In addition, cefepime is used alone or in conjunction with other anti-infectives for empiric anti-infective therapy in febrile neutropenic patients.
Generic name: CEFEPIME HCL (SEF-e-peem)
Drug class: Beta-Lactams
Therapeutic class: Anti-Infective Agents
Cefepime is a semisynthetic, fourth generation cephalosporin antibiotic.
Cefepime is used for the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, and moderate to severe pneumonia caused by susceptible organisms. For the treatment of complicated intra-abdominal infections, cefepime is used in conjunction with IV metronidazole. In addition, cefepime is used alone or in conjunction with other anti-infectives for empiric anti-infective therapy in febrile neutropenic patients.
DRUG IMAGES
CEFEPIME HCL 1 GM VIAL
CEFEPIME HCL 2 GRAM VIAL
The following indications for CEFEPIME HCL (cefepime hcl) have been approved by the FDA:
Indications:
Bacterial pneumonia
Bacterial urinary tract infection
Complicated bacterial infection of urinary tract
Complicated Bacteroides peritonitis
Complicated E. coli peritonitis
Complicated E. coli UTI
Complicated Enterobacter peritonitis
Complicated Klebsiella peritonitis
Complicated Proteus UTI
Complicated Pseudomonas aeruginosa peritonitis
Complicated Streptococcus peritonitis
E. coli pyelonephritis
E. coli urinary tract infection
Enterobacter pneumonia
Febrile neutropenic patient presumed infection treatment
Infectious disease of abdomen
Klebsiella complicated UTI
Klebsiella pneumonia
Klebsiella pyelonephritis
Klebsiella urinary tract infection
Pneumococcal pneumonia
Proteus pyelonephritis
Proteus urinary tract infection
Pseudomonas aeruginosa pneumonia
Skin and skin structure Streptococcus pyogenes infection
Staphylococcus aureus skin and skin structure infection
Streptococcal pneumonia
Professional Synonyms:
Complicated bacterial urinary tract infection
Complicated peritonitis due to Bacteroides species
Complicated peritonitis due to E. coli
Complicated peritonitis due to Enterobacter species
Complicated peritonitis due to Escherichia coli
Complicated peritonitis due to Klebsiella species
Complicated peritonitis due to Pseudomonas aeruginosa
Complicated peritonitis due to Streptococcus species
Complicated urinary tract infection due to Escherichia coli
Complicated urinary tract infection due to Klebsiella
Complicated urinary tract Proteus species infection
Complicated UTI due to E. coli
Complicated UTI due to Klebsiella species
Complicated UTI due to Proteus species
E. coli UTI
Empiric therapy in febrile neutropenia
Empiric therapy of infection in febrile neutrophilic leukocytopenia
Empiric therapy of infection in febrile neutrophilopenia
Infection of the lungs due to Enterobacter
Infection of the lungs due to Pseudomonas aeruginosa
Intra-abdominal infection
Klebsiella UTI
Nephropyelitis due to Escherichia coli
Nephropyelitis due to Klebsiella species
Nephropyelitis due to Proteus species
Pneumonia due to Klebsiella species
Pneumonia due to Klebsiella spp.
Pneumonia due to Pseudomonas aeruginosa
Pneumonia due to Streptococcus pneumoniae
Pneumonia due to Streptococcus species
Pneumonia due to Streptococcus spp.
Presumed infection in febrile neutropenic patient
Pyelonephritis due to E. coli
Pyelonephritis due to Escherichia coli
Pyelonephritis due to Klebsiella species
Pyelonephritis due to Proteus species
Renal & pelvis renalis infection due to Klebsiella
Renal & ureteric pelvis infection due to Escherichia coli
Renal & ureteric pelvis infection due to Klebsiella
Renal and pelvis renalis Escherichia coli infection
Renal and pelvis renalis infection due to Proteus species
Renal and ureteric pelvis infection due to Proteus species
Skin & skin soft tissue Streptococcus pyogenes infection
Skin and skin soft tissue Staphylococcus aureus infection
Urinary tract infection due to Escherichia coli
Urinary tract infection due to Klebsiella species
Urinary tract infection due to Proteus species
UTI due to Proteus species
Indications:
Bacterial pneumonia
Bacterial urinary tract infection
Complicated bacterial infection of urinary tract
Complicated Bacteroides peritonitis
Complicated E. coli peritonitis
Complicated E. coli UTI
Complicated Enterobacter peritonitis
Complicated Klebsiella peritonitis
Complicated Proteus UTI
Complicated Pseudomonas aeruginosa peritonitis
Complicated Streptococcus peritonitis
E. coli pyelonephritis
E. coli urinary tract infection
Enterobacter pneumonia
Febrile neutropenic patient presumed infection treatment
Infectious disease of abdomen
Klebsiella complicated UTI
Klebsiella pneumonia
Klebsiella pyelonephritis
Klebsiella urinary tract infection
Pneumococcal pneumonia
Proteus pyelonephritis
Proteus urinary tract infection
Pseudomonas aeruginosa pneumonia
Skin and skin structure Streptococcus pyogenes infection
Staphylococcus aureus skin and skin structure infection
Streptococcal pneumonia
Professional Synonyms:
Complicated bacterial urinary tract infection
Complicated peritonitis due to Bacteroides species
Complicated peritonitis due to E. coli
Complicated peritonitis due to Enterobacter species
Complicated peritonitis due to Escherichia coli
Complicated peritonitis due to Klebsiella species
Complicated peritonitis due to Pseudomonas aeruginosa
Complicated peritonitis due to Streptococcus species
Complicated urinary tract infection due to Escherichia coli
Complicated urinary tract infection due to Klebsiella
Complicated urinary tract Proteus species infection
Complicated UTI due to E. coli
Complicated UTI due to Klebsiella species
Complicated UTI due to Proteus species
E. coli UTI
Empiric therapy in febrile neutropenia
Empiric therapy of infection in febrile neutrophilic leukocytopenia
Empiric therapy of infection in febrile neutrophilopenia
Infection of the lungs due to Enterobacter
Infection of the lungs due to Pseudomonas aeruginosa
Intra-abdominal infection
Klebsiella UTI
Nephropyelitis due to Escherichia coli
Nephropyelitis due to Klebsiella species
Nephropyelitis due to Proteus species
Pneumonia due to Klebsiella species
Pneumonia due to Klebsiella spp.
Pneumonia due to Pseudomonas aeruginosa
Pneumonia due to Streptococcus pneumoniae
Pneumonia due to Streptococcus species
Pneumonia due to Streptococcus spp.
Presumed infection in febrile neutropenic patient
Pyelonephritis due to E. coli
Pyelonephritis due to Escherichia coli
Pyelonephritis due to Klebsiella species
Pyelonephritis due to Proteus species
Renal & pelvis renalis infection due to Klebsiella
Renal & ureteric pelvis infection due to Escherichia coli
Renal & ureteric pelvis infection due to Klebsiella
Renal and pelvis renalis Escherichia coli infection
Renal and pelvis renalis infection due to Proteus species
Renal and ureteric pelvis infection due to Proteus species
Skin & skin soft tissue Streptococcus pyogenes infection
Skin and skin soft tissue Staphylococcus aureus infection
Urinary tract infection due to Escherichia coli
Urinary tract infection due to Klebsiella species
Urinary tract infection due to Proteus species
UTI due to Proteus species
The following dosing information is available for CEFEPIME HCL (cefepime hcl):
Cefepime is commercially available as cefepime hydrochloride, which is monohydrated; dosage is expressed in terms of cefepime, calculated on the anhydrous basis.
For the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, or pneumonia, the manufacturers recommend that pediatric patients 2 months to 16 years of age weighing less than 40 kg receive cefepime in a dosage of 50 mg/kg given IV every 12 hours. Pediatric dosage should not exceed the recommended adult dosage.
Although safety and efficacy of cefepime have not been established in neonates or infants younger than 2 months of age, the American Academy of Pediatrics (AAP) states that neonates 28 days of age or younger+ may receive IV or IM cefepime in a dosage of 30 mg/kg every 12 hours and that a dosage of 50 mg/kg every 12 hours may be required for Pseudomonas infections.
The AAP states that pediatric patients beyond the neonatal period may receive IV or IM cefepime in a dosage of 100 mg/kg daily in 2 equally divided doses for the treatment of mild to moderate infections or a dosage of 100-150 mg/kg daily in 2 or 3 equally divided doses for the treatment of severe infections.
To avoid unintentional overdosage, the manufacturers state that the commercially available Duplex(R) drug delivery systems containing cefepime and the commercially available frozen premixed cefepime injection should not be used in pediatric patients who require less than the entire 1- or 2-g dose in the container.
In patients with renal impairment (i.e., creatinine clearance of 60 mL/minute or less), doses and/or frequency of administration of cefepime should be modified in response to the degree of renal impairment, severity of the infection, and susceptibility of the causative organism.
The manufacturers recommend that adults with creatinine clearance of 60 mL/minute or less (not receiving hemodialysis) receive the same initial dose of cefepime recommended for patients with normal renal function followed by a maintenance dosage of cefepime based on the patient's measured or estimated creatinine clearance. (See Table 1 and Table 2.)
Table 1. Maintenance Dosage for Treatment of Infections in Adults with Renal Impairment
Creatinine Initial dose: 500 Initial dose: 1 g Initial dose: 2 g Clearance mg (mL/minute) 30-60 500 mg every 24 h 1 g every 24 h 2 g every 24 h 11-29 500 mg every 24 h 500 mg every 24 h 1 g every 24 h <11 250 mg every 24 h 250 mg every 24 h 500 mg every 24 h
Table 2. Maintenance Dosage for Empiric Therapy in Febrile Neutropenic Adults with Renal Impairment
Creatinine Clearance (mL/minute) Initial Dose: 2 g 30-60 2 g every 12 h 11-29 2 g every 24 h <11 1 g every 24 h
The manufacturers recommend that adults undergoing hemodialysis receive an initial 1-g dose of cefepime on day 1, then 500 mg once daily thereafter for the treatment of infections or 1 g once daily for empiric therapy of presumed bacterial infections in febrile neutropenic patients. The manufacturers also recommend that the daily dose be given at the same time of day whenever possible; on hemodialysis days, the dose should be given after the procedure.
Adults undergoing continuous ambulatory peritoneal dialysis (CAPD) should receive the usual cefepime dose every 48 hours.
Data regarding use of cefepime in pediatric patients with impaired renal function are not available. Because the pharmacokinetics of cefepime are similar in pediatric and adult patients, the manufacturers recommend that dosage modifications proportional to those recommended for adults be used in pediatric patients with impaired renal function.
Since pharmacokinetics of cefepime appear not to be altered in patients with hepatic impairment, the manufacturers state that dosage adjustments are not necessary in such patients.
For the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, or pneumonia, the manufacturers recommend that pediatric patients 2 months to 16 years of age weighing less than 40 kg receive cefepime in a dosage of 50 mg/kg given IV every 12 hours. Pediatric dosage should not exceed the recommended adult dosage.
Although safety and efficacy of cefepime have not been established in neonates or infants younger than 2 months of age, the American Academy of Pediatrics (AAP) states that neonates 28 days of age or younger+ may receive IV or IM cefepime in a dosage of 30 mg/kg every 12 hours and that a dosage of 50 mg/kg every 12 hours may be required for Pseudomonas infections.
The AAP states that pediatric patients beyond the neonatal period may receive IV or IM cefepime in a dosage of 100 mg/kg daily in 2 equally divided doses for the treatment of mild to moderate infections or a dosage of 100-150 mg/kg daily in 2 or 3 equally divided doses for the treatment of severe infections.
To avoid unintentional overdosage, the manufacturers state that the commercially available Duplex(R) drug delivery systems containing cefepime and the commercially available frozen premixed cefepime injection should not be used in pediatric patients who require less than the entire 1- or 2-g dose in the container.
In patients with renal impairment (i.e., creatinine clearance of 60 mL/minute or less), doses and/or frequency of administration of cefepime should be modified in response to the degree of renal impairment, severity of the infection, and susceptibility of the causative organism.
The manufacturers recommend that adults with creatinine clearance of 60 mL/minute or less (not receiving hemodialysis) receive the same initial dose of cefepime recommended for patients with normal renal function followed by a maintenance dosage of cefepime based on the patient's measured or estimated creatinine clearance. (See Table 1 and Table 2.)
Table 1. Maintenance Dosage for Treatment of Infections in Adults with Renal Impairment
Creatinine Initial dose: 500 Initial dose: 1 g Initial dose: 2 g Clearance mg (mL/minute) 30-60 500 mg every 24 h 1 g every 24 h 2 g every 24 h 11-29 500 mg every 24 h 500 mg every 24 h 1 g every 24 h <11 250 mg every 24 h 250 mg every 24 h 500 mg every 24 h
Table 2. Maintenance Dosage for Empiric Therapy in Febrile Neutropenic Adults with Renal Impairment
Creatinine Clearance (mL/minute) Initial Dose: 2 g 30-60 2 g every 12 h 11-29 2 g every 24 h <11 1 g every 24 h
The manufacturers recommend that adults undergoing hemodialysis receive an initial 1-g dose of cefepime on day 1, then 500 mg once daily thereafter for the treatment of infections or 1 g once daily for empiric therapy of presumed bacterial infections in febrile neutropenic patients. The manufacturers also recommend that the daily dose be given at the same time of day whenever possible; on hemodialysis days, the dose should be given after the procedure.
Adults undergoing continuous ambulatory peritoneal dialysis (CAPD) should receive the usual cefepime dose every 48 hours.
Data regarding use of cefepime in pediatric patients with impaired renal function are not available. Because the pharmacokinetics of cefepime are similar in pediatric and adult patients, the manufacturers recommend that dosage modifications proportional to those recommended for adults be used in pediatric patients with impaired renal function.
Since pharmacokinetics of cefepime appear not to be altered in patients with hepatic impairment, the manufacturers state that dosage adjustments are not necessary in such patients.
No enhanced Administration information available for this drug.
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| CEFEPIME HCL 1 GM VIAL | Maintenance | Adults infuse 1 gram by intravenous route every 12 hours |
| CEFEPIME HCL 2 GRAM VIAL | Maintenance | Adults infuse 2 gram over 30 minute(s) by intravenous route every 12 hours |
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| CEFEPIME HCL 1 GM VIAL | Maintenance | Adults infuse 1 gram by intravenous route every 12 hours |
| CEFEPIME HCL 2 GRAM VIAL | Maintenance | Adults infuse 2 gram over 30 minute(s) by intravenous route every 12 hours |
The following drug interaction information is available for CEFEPIME HCL (cefepime hcl):
There are 1 contraindications.
These drug combinations generally should not be dispensed or administered to the same patient. A manufacturer label warning that indicates the contraindication warrants inclusion of a drug combination in this category, regardless of clinical evidence or lack of clinical evidence to support the contraindication.
| Drug Interaction | Drug Names |
|---|---|
| Live Typhoid Vaccine/Antimicrobials SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: The antimicrobial may be active against the organism in the live-vaccine. Antimicrobial therapy may prevent the vaccine organism from replicating enough to trigger an immune response.(1) CLINICAL EFFECTS: Vaccination may be ineffective. PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Do not give oral typhoid vaccine until 72 hours after the last dose of antimicrobial. If possible, to optimize vaccine effectiveness, do not start antibacterial drugs for 72 hours after the last dose of oral typhoid vaccine. A longer interval should be considered for long-acting antimicrobials, such as azithromycin.(3) DISCUSSION: Because antimicrobial therapy may prevent sufficient vaccine-organism replication to generate an immune response, the manufacturer of live-attenuated typhoid vaccine and the Centers for Disease Control (CDC) state that the vaccine should not be administered to patients receiving antimicrobial therapy.(1-3) |
VIVOTIF |
There are 1 severe interactions.
These drug interactions can produce serious consequences in most patients. Actions required for severe interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration scheduling, and providing additional patient monitoring. Review the full interaction monograph for more information.
| Drug Interaction | Drug Names |
|---|---|
| Fecal Microbiota Spores/Antibiotics SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: Fecal microbiota spores is a suspension of live bacterial spores, which may be compromised by concurrent use of antibiotics.(1) CLINICAL EFFECTS: Antibiotics may decrease the effectiveness of fecal microbiota spores.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Antibiotics should not be used concurrently with fecal microbiota spores. Antibacterial treatment should be completed for 2 to 4 days before initiating treatment with fecal microbiota spores.(1) DISCUSSION: Antibiotics may compromise the effectiveness of fecal microbiota spores. |
VOWST |
There are 1 moderate interactions.
The clinician should assess the patient’s characteristics and take action as needed. Actions required for moderate interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration.
| Drug Interaction | Drug Names |
|---|---|
| Selected Cephalosporins & Penicillins/Probenecid SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed. MECHANISM OF ACTION: Probenecid impairs the clearance of some cephalosporins and penicillins via inhibition of renal anion transporters in the proximal tubule.(49) It has also been hypothesized that probenecid may affect tissue distribution of cephalosporins.(1-5) CLINICAL EFFECTS: The concurrent administration of probenecid may result in increased maximum concentration (Cmax), area-under-curve (AUC), and half-life of the cephalosporin or penicillin.(49) While this may improve antibiotic efficacy,(46-48) increased levels may also increase the risk for antibiotic-associated nephrotoxicity.(4) PREDISPOSING FACTORS: Underlying renal dysfunction may increase the risk for nephrotoxicity. PATIENT MANAGEMENT: In patients receiving the combination to improve antibiotic efficacy, monitor for antibiotic adverse effects and consider monitoring renal function. In patients receiving probenecid therapy to prevent or treat hyperuricemia, exposure to the antibiotic will be increased. A decrease in antibiotic dose or frequency may be required. The US manufacturer of piperacillin-tazobactam states probenecid should not be coadministered with piperacillin-tazobactam unless the benefit outweighs the risk.(50) DISCUSSION: Concurrent use of probenecid with a cephalosporin or penicillin may cause an increase in the Cmax, AUC, and an increased elimination half life of the antibiotic.(6-8,49) This may be beneficial or necessary in difficult to treat infections,(46-48) but an increased risk for adverse effects should be expected. Antibiotics not dose adjusted for concurrent use with probenecid may be associated with an increased risk for adverse effects, such as nephrotoxicity. Probenecid administered concurrently with piperacillin-tazobactam prolongs the half-life of piperacillin by 21% and tazobactam by 71%. In a study in 8 healthy males, concurrent administration of probenecid (1 g) with piperacillin (1 g IM) increased piperacillin's Cmax and AUC by 30% and 60%. Renal clearance was reduced by 40%.(51) The cephalosporins affected by probenecid include cefazolin,(9-11) cephacetrile,(12,13) cephaloglycin,(14,15) cephalexin,(16-21) cephradine, (22-23) cefoxitin,(24-28) cefadroxil(29), cefaclor,(23) cefamandole,(30) ceftizoxime,(31,32) cefuroxime,(33,34) cefprozil,(35) cefonicid,(36) cefmetazole,(37) cefmenoxime,(38) and cefditoren.(39) Probenecid has been shown not to affect moxalactam,(4,40,41) ceforanide, (4,42), cefoperazone, ceftazidime(4,34,43) or ceftriaxone.(4) |
PROBENECID, PROBENECID-COLCHICINE |
The following contraindication information is available for CEFEPIME HCL (cefepime hcl):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 6 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Chronic kidney disease stage 3A (moderate) GFR 45-59 ml/min |
| Chronic kidney disease stage 3B (moderate) GFR 30-44 ml/min |
| Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
| Chronic kidney disease stage 5 (failure) GFr<15 ml/min |
| Clostridioides difficile infection |
| Seizure disorder |
There are 5 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Colitis |
| Hypoprothrombinemia |
| Increased risk of bleeding |
| Kidney disease with likely reduction in glomerular filtration rate (GFr) |
| Myoclonus |
The following adverse reaction information is available for CEFEPIME HCL (cefepime hcl):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 35 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Abnormal hepatic function tests Hypophosphatemia Increased alanine transaminase Increased aspartate transaminase Injection site sequelae Pruritus of skin Skin rash |
Drug fever Hypersensitivity drug reaction |
| Rare/Very Rare |
|---|
|
Acute generalized exanthematous pustulosis Agranulocytosis Anaphylaxis Anemia Aphasia Aplastic anemia Cholestasis Clostridioides difficile infection Colitis Coma DRESS syndrome Encephalopathy Erythema multiforme Hemolytic anemia Hypoprothrombinemia Kidney disease with reduction in glomerular filtration rate (GFr) Leukopenia Myoclonus Neutropenic disorder Nonconvulsive status epilepticus Pancytopenia Seizure disorder Stevens-johnson syndrome Stupor Thrombocytopenic disorder Toxic epidermal necrolysis |
There are 13 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Diarrhea Headache disorder Nausea Vomiting |
Erythema Gastrointestinal irritation Oral candidiasis Phlebitis after infusion Vaginitis Vulvovaginal candidiasis |
| Rare/Very Rare |
|---|
|
Acute cognitive impairment Hallucinations Urticaria |
The following precautions are available for CEFEPIME HCL (cefepime hcl):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Reproduction studies in rats, rabbits, or mice using cefepime dosages approximately 1.6 times or 0.3 times, or equal to the recommended maximum human dosage (calculated on a mg/m2 basis), respectively, have not revealed evidence of teratogenicity or embryotoxicity. There are no adequate and controlled studies using cefepime in pregnant women or during labor and delivery, and the drug should be used during pregnancy only when clearly needed.
Cefepime is distributed into milk in low concentrations following parenteral administration, and the drug should be used with caution in nursing women.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for CEFEPIME HCL (cefepime hcl):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for CEFEPIME HCL (cefepime hcl)'s list of indications:
| Bacterial pneumonia | |
| J15.9 | Unspecified bacterial pneumonia |
| Bacterial urinary tract infection | |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| P39.3 | Neonatal urinary tract infection |
| T83 | Complications of genitourinary prosthetic devices, implants and grafts |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.6 | Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract |
| Complicated bacterial infection of urinary tract | |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
| T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
| T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
| T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
| T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
| T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
| T83.518 | Infection and inflammatory reaction due to other urinary catheter |
| T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
| T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
| T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
| T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
| T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
| T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
| T83.593 | Infection and inflammatory reaction due to other urinary stents |
| T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
| T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
| T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
| Complicated bacteroides peritonitis | |
| B96.6 | Bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Complicated e. coli peritonitis | |
| B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
| B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Complicated e. coli UTI | |
| B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
| B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
| T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
| T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
| T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
| T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
| T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
| T83.518 | Infection and inflammatory reaction due to other urinary catheter |
| T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
| T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
| T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
| T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
| T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
| T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
| T83.593 | Infection and inflammatory reaction due to other urinary stents |
| T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
| T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
| T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
| Complicated enterobacter peritonitis | |
| B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Complicated klebsiella peritonitis | |
| B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Complicated proteus UTI | |
| B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
| T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
| T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
| T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
| T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
| T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
| T83.518 | Infection and inflammatory reaction due to other urinary catheter |
| T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
| T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
| T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
| T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
| T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
| T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
| T83.593 | Infection and inflammatory reaction due to other urinary stents |
| T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
| T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
| T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
| Complicated pseudomonas aeruginosa peritonitis | |
| B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Complicated streptococcus peritonitis | |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| B95.1 | Streptococcus, group b, as the cause of diseases classified elsewhere |
| B95.3 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
| B95.4 | Other streptococcus as the cause of diseases classified elsewhere |
| B95.5 | Unspecified streptococcus as the cause of diseases classified elsewhere |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| E. coli pyelonephritis | |
| B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
| B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| N10 | Acute pyelonephritis |
| N12 | Tubulo-interstitial nephritis, not specified as acute or chronic |
| N39.0 | Urinary tract infection, site not specified |
| E. coli urinary tract infection | |
| B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
| B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.9 | Unspecified genitourinary tract infection in pregnancy |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| Enterobacter pneumonia | |
| J15.6 | Pneumonia due to other gram-negative bacteria |
| Febrile neutropenic patient presumed infection treatment | |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
| D70.2 | Other drug-induced agranulocytosis |
| D70.3 | Neutropenia due to infection |
| D70.8 | Other neutropenia |
| D70.9 | Neutropenia, unspecified |
| R50.81 | Fever presenting with conditions classified elsewhere |
| Infectious disease of abdomen | |
| A51.1 | Primary anal syphilis |
| K35 | Acute appendicitis |
| K35.2 | Acute appendicitis with generalized peritonitis |
| K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
| K35.200 | Acute appendicitis with generalized peritonitis, without perforation or abscess |
| K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
| K35.209 | Acute appendicitis with generalized peritonitis, without abscess, unspecified as to perforation |
| K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
| K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
| K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
| K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
| K35.3 | Acute appendicitis with localized peritonitis |
| K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
| K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
| K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
| K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
| K35.8 | Other and unspecified acute appendicitis |
| K35.80 | Unspecified acute appendicitis |
| K35.89 | Other acute appendicitis |
| K35.890 | Other acute appendicitis without perforation or gangrene |
| K35.891 | Other acute appendicitis without perforation, with gangrene |
| K65.0 | Generalized (acute) peritonitis |
| K65.2 | Spontaneous bacterial peritonitis |
| Klebsiella complicated UTI | |
| B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
| T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
| T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
| T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
| T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
| T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
| T83.518 | Infection and inflammatory reaction due to other urinary catheter |
| T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
| T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
| T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
| T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
| T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
| T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
| T83.593 | Infection and inflammatory reaction due to other urinary stents |
| T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
| T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
| T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
| Klebsiella pneumonia | |
| J15.0 | Pneumonia due to klebsiella pneumoniae |
| Klebsiella pyelonephritis | |
| B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
| N10 | Acute pyelonephritis |
| N12 | Tubulo-interstitial nephritis, not specified as acute or chronic |
| N39.0 | Urinary tract infection, site not specified |
| Klebsiella urinary tract infection | |
| B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.9 | Unspecified genitourinary tract infection in pregnancy |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| Pneumococcal pneumonia | |
| J13 | Pneumonia due to streptococcus pneumoniae |
| Proteus pyelonephritis | |
| B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
| N10 | Acute pyelonephritis |
| N12 | Tubulo-interstitial nephritis, not specified as acute or chronic |
| N39.0 | Urinary tract infection, site not specified |
| Proteus urinary tract infection | |
| B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.9 | Unspecified genitourinary tract infection in pregnancy |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| Pseudomonas aeruginosa pneumonia | |
| J15.1 | Pneumonia due to pseudomonas |
| Skin and skin structure strep. pyogenes infection | |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| B95.4 | Other streptococcus as the cause of diseases classified elsewhere |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| Staphylococcus aureus skin and skin structure infection | |
| B95.6 | Staphylococcus aureus as the cause of diseases classified elsewhere |
| H60.1 | Cellulitis of external ear |
| H60.10 | Cellulitis of external ear, unspecified ear |
| H60.11 | Cellulitis of right external ear |
| H60.12 | Cellulitis of left external ear |
| H60.13 | Cellulitis of external ear, bilateral |
| J34.0 | Abscess, furuncle and carbuncle of nose |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L02.0 | Cutaneous abscess, furuncle and carbuncle of face |
| L02.02 | Furuncle of face |
| L02.03 | Carbuncle of face |
| L02.1 | Cutaneous abscess, furuncle and carbuncle of neck |
| L02.12 | Furuncle of neck |
| L02.13 | Carbuncle of neck |
| L02.2 | Cutaneous abscess, furuncle and carbuncle of trunk |
| L02.22 | Furuncle of trunk |
| L02.221 | Furuncle of abdominal wall |
| L02.222 | Furuncle of back [any part, except buttock] |
| L02.223 | Furuncle of chest wall |
| L02.224 | Furuncle of groin |
| L02.225 | Furuncle of perineum |
| L02.226 | Furuncle of umbilicus |
| L02.229 | Furuncle of trunk, unspecified |
| L02.23 | Carbuncle of trunk |
| L02.231 | Carbuncle of abdominal wall |
| L02.232 | Carbuncle of back [any part, except buttock] |
| L02.233 | Carbuncle of chest wall |
| L02.234 | Carbuncle of groin |
| L02.235 | Carbuncle of perineum |
| L02.236 | Carbuncle of umbilicus |
| L02.239 | Carbuncle of trunk, unspecified |
| L02.3 | Cutaneous abscess, furuncle and carbuncle of buttock |
| L02.32 | Furuncle of buttock |
| L02.33 | Carbuncle of buttock |
| L02.4 | Cutaneous abscess, furuncle and carbuncle of limb |
| L02.42 | Furuncle of limb |
| L02.421 | Furuncle of right axilla |
| L02.422 | Furuncle of left axilla |
| L02.423 | Furuncle of right upper limb |
| L02.424 | Furuncle of left upper limb |
| L02.425 | Furuncle of right lower limb |
| L02.426 | Furuncle of left lower limb |
| L02.429 | Furuncle of limb, unspecified |
| L02.43 | Carbuncle of limb |
| L02.431 | Carbuncle of right axilla |
| L02.432 | Carbuncle of left axilla |
| L02.433 | Carbuncle of right upper limb |
| L02.434 | Carbuncle of left upper limb |
| L02.435 | Carbuncle of right lower limb |
| L02.436 | Carbuncle of left lower limb |
| L02.439 | Carbuncle of limb, unspecified |
| L02.5 | Cutaneous abscess, furuncle and carbuncle of hand |
| L02.52 | Furuncle hand |
| L02.521 | Furuncle right hand |
| L02.522 | Furuncle left hand |
| L02.529 | Furuncle unspecified hand |
| L02.53 | Carbuncle of hand |
| L02.531 | Carbuncle of right hand |
| L02.532 | Carbuncle of left hand |
| L02.539 | Carbuncle of unspecified hand |
| L02.6 | Cutaneous abscess, furuncle and carbuncle of foot |
| L02.62 | Furuncle of foot |
| L02.621 | Furuncle of right foot |
| L02.622 | Furuncle of left foot |
| L02.629 | Furuncle of unspecified foot |
| L02.63 | Carbuncle of foot |
| L02.631 | Carbuncle of right foot |
| L02.632 | Carbuncle of left foot |
| L02.639 | Carbuncle of unspecified foot |
| L02.8 | Cutaneous abscess, furuncle and carbuncle of other sites |
| L02.82 | Furuncle of other sites |
| L02.821 | Furuncle of head [any part, except face] |
| L02.828 | Furuncle of other sites |
| L02.83 | Carbuncle of other sites |
| L02.831 | Carbuncle of head [any part, except face] |
| L02.838 | Carbuncle of other sites |
| L02.9 | Cutaneous abscess, furuncle and carbuncle, unspecified |
| L02.92 | Furuncle, unspecified |
| L02.93 | Carbuncle, unspecified |
| L03.01 | Cellulitis of finger |
| L03.011 | Cellulitis of right finger |
| L03.012 | Cellulitis of left finger |
| L03.019 | Cellulitis of unspecified finger |
| L03.03 | Cellulitis of toe |
| L03.031 | Cellulitis of right toe |
| L03.032 | Cellulitis of left toe |
| L03.039 | Cellulitis of unspecified toe |
| L03.1 | Cellulitis and acute lymphangitis of other parts of limb |
| L03.11 | Cellulitis of other parts of limb |
| L03.111 | Cellulitis of right axilla |
| L03.112 | Cellulitis of left axilla |
| L03.113 | Cellulitis of right upper limb |
| L03.114 | Cellulitis of left upper limb |
| L03.115 | Cellulitis of right lower limb |
| L03.116 | Cellulitis of left lower limb |
| L03.119 | Cellulitis of unspecified part of limb |
| L03.2 | Cellulitis and acute lymphangitis of face and neck |
| L03.21 | Cellulitis and acute lymphangitis of face |
| L03.211 | Cellulitis of face |
| L03.22 | Cellulitis and acute lymphangitis of neck |
| L03.221 | Cellulitis of neck |
| L03.3 | Cellulitis and acute lymphangitis of trunk |
| L03.31 | Cellulitis of trunk |
| L03.311 | Cellulitis of abdominal wall |
| L03.312 | Cellulitis of back [any part except buttock] |
| L03.313 | Cellulitis of chest wall |
| L03.314 | Cellulitis of groin |
| L03.315 | Cellulitis of perineum |
| L03.316 | Cellulitis of umbilicus |
| L03.317 | Cellulitis of buttock |
| L03.319 | Cellulitis of trunk, unspecified |
| L03.8 | Cellulitis and acute lymphangitis of other sites |
| L03.81 | Cellulitis of other sites |
| L03.811 | Cellulitis of head [any part, except face] |
| L03.818 | Cellulitis of other sites |
| L03.9 | Cellulitis and acute lymphangitis, unspecified |
| L03.90 | Cellulitis, unspecified |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| N48.22 | Cellulitis of corpus cavernosum and penis |
| Streptococcal pneumonia | |
| J13 | Pneumonia due to streptococcus pneumoniae |
| J15.3 | Pneumonia due to streptococcus, group B |
| J15.4 | Pneumonia due to other streptococci |
Formulary Reference Tool